Development of nalidixic acid amphotericin B vancomycin (NAV) medium for the isolation of Campylobacter ureolyticus from the stools of patients presenting with acute gastroenteritis.
about
Under the microscope: From pathogens to probiotics and back.Towards understanding clinical campylobacter infection and its transmission: time for a different approach?Detection and molecular analysis of Campylobacter ureolyticus in domestic animals.The rolling evolution of biomedical science as an essential tool in modern clinical practice.
P2860
Development of nalidixic acid amphotericin B vancomycin (NAV) medium for the isolation of Campylobacter ureolyticus from the stools of patients presenting with acute gastroenteritis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Development of nalidixic acid ...... ng with acute gastroenteritis.
@en
Development of nalidixic acid amphotericin B vancomycin
@nl
type
label
Development of nalidixic acid ...... ng with acute gastroenteritis.
@en
Development of nalidixic acid amphotericin B vancomycin
@nl
prefLabel
Development of nalidixic acid ...... ng with acute gastroenteritis.
@en
Development of nalidixic acid amphotericin B vancomycin
@nl
P2093
P921
P1476
Development of nalidixic acid ...... ng with acute gastroenteritis.
@en
P2093
A O'Doherty
D Corcoran
L De Barra
R D Sleator
P356
10.1080/09674845.2014.11669956
P50
P577
2014-01-01T00:00:00Z